FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

BACKGROUND: The burden of non-alcoholic fatty liver disease (NAFLD) is increasing globally, and a major priority is to identify patients with non-alcoholic steatohepatitis (NASH) who are at greater risk of progression to cirrhosis, and who will be candidates for clinical trials and emerging new phar...

Descripción completa

Detalles Bibliográficos
Autores principales: Newsome, Philip N, Sasso, Magali, Deeks, Jonathan J, Paredes, Angelo, Boursier, Jérôme, Chan, Wah-Kheong, Yilmaz, Yusuf, Czernichow, Sébastien, Zheng, Ming-Hua, Wong, Vincent Wai-Sun, Allison, Michael, Tsochatzis, Emmanuel, Anstee, Quentin M, Sheridan, David A, Eddowes, Peter J, Guha, Indra N, Cobbold, Jeremy F, Paradis, Valérie, Bedossa, Pierre, Miette, Véronique, Fournier-Poizat, Céline, Sandrin, Laurent, Harrison, Stephen A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066580/
https://www.ncbi.nlm.nih.gov/pubmed/32027858
http://dx.doi.org/10.1016/S2468-1253(19)30383-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066580/
https://www.ncbi.nlm.nih.gov/pubmed/32027858
http://dx.doi.org/10.1016/S2468-1253(19)30383-8

Ejemplares similares